MyoD公司
C2C12型
心肌细胞
骨骼肌
肌肉萎缩
内分泌学
下调和上调
内科学
化学
肌发生
细胞生物学
生物
生物化学
医学
基因
作者
Qing Li,Genying Li,Ziyuan Wang,Na Xi,Gaoqi Ye,Zhaofeng Li,Jie Liu
摘要
Abstract Background Alkylresorcinols (ARs) are phenolic lipids and widely distributed in whole grains such as wheat and rye. Obesity‐induced skeletal muscle dysregulation is exhibited as muscle weakness and muscle atrophy. ARs have been demonstrated to mitigate muscle dysfunction, while their potential role in modulating myotube differentiation and myofiber type transition remains unclear. This study employed palmitic acid‐treated C2C12 cells and high‐fat diet (HFD)‐induced murine models to elucidate the underlying mechanisms through which ARs potentially ameliorate skeletal muscle impairment associated with obesity. Results The results showed that ARs significantly increased exercise capacity of HFD‐fed mice. The transformation from fast‐twitch myofibers to slow‐twitch myofibers, muscle growth and differentiation were improved by ARs treatment in obese mice. The expression levels of MyoD, MyoG and slow‐MyHC proteins were upregulated, and the expression levels of MSTN and fast‐MyHC proteins were downregulated after ARs intervention. Furthermore, ARs exhibited beneficial effects by regulating the miR‐34a/SIRT1 axis which was evidenced by inhibiting the level of miR‐34a and increasing the level of downstream SIRT1. Additionally, the expression of MyoD, MyoG and slow‐MyHC proteins was decreased in miR‐34a mimic‐transfected C2C12 cells, while ARs pretreatment abolished this trend. Conclusion These findings indicate that ARs exert essential roles in obesity‐associated skeletal muscle dysfunction via the miR‐34a/SIRT1 axis. © 2025 Society of Chemical Industry.
科研通智能强力驱动
Strongly Powered by AbleSci AI